The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta
- PMID: 32945767
- PMCID: PMC7553214
- DOI: 10.5888/pcd17.200063
The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta
Abstract
Introduction: The Mississippi Delta has high rates of chronic disease and is known for its poor health outcomes and health disparities. The University of Mississippi School of Pharmacy (UMSOP) and the Mississippi State Department of Health partnered in 2009 through the Mississippi Delta Health Collaborative to reduce health disparities and improve clinical outcomes by expanding the UMSOP's evidence-based medication therapy management (MTM) initiative, focused in Mississippi's 18-county Delta region, to federally qualified health centers (FQHCs) in 4 of those counties.
Methods: Between January 2009 and August 2018, the MTM initiative targeted FQHC patients aged 18 years or older with a diagnosis of diabetes, hypertension, and/or dyslipidemia. Pharmacists initially met face-to-face with patients to review all medications, provide education about chronic diseases, identify and resolve drug therapy problems, and take appropriate actions to help improve the effectiveness of medication therapies. Clinical parameters evaluated were systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, and hemoglobin A1c (HbA1c).
Results: The analysis included 335 patients with hypertension (n = 287), dyslipidemia (n = 131), and/or diabetes (n = 331). Significant mean reductions occurred in the following metrics: SBP (7.1 mm Hg), DBP (6.3 mm Hg), LDL cholesterol (24.9 mg/dL), triglycerides (45.5 mg/dL), total cholesterol (37.7 mg/dL), and HbA1c (1.6% [baseline ≥6%] and 1.9% [baseline ≥9%]).
Conclusion: Despite the cultural and environmental disadvantages present in the Mississippi Delta, the integrated MTM treatment program demonstrated significant health improvements across 3 chronic diseases: hypertension, dyslipidemia, and diabetes. This model demonstrates that a partnership between public health and pharmacy is a successful and innovative approach to care.
Figures

Similar articles
-
Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or Hypertension.J Manag Care Spec Pharm. 2018 Feb;24(2):132-141. doi: 10.18553/jmcp.2018.24.2.132. J Manag Care Spec Pharm. 2018. PMID: 29384026 Free PMC article.
-
The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):23-31. doi: 10.1331/JAPhA.2008.07140. J Am Pharm Assoc (2003). 2008. PMID: 18192127
-
Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45. doi: 10.18553/jmcp.2014.20.10.1036. J Manag Care Spec Pharm. 2014. PMID: 25278326 Free PMC article.
-
Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.J Am Heart Assoc. 2019 Nov 19;8(22):e013627. doi: 10.1161/JAHA.119.013627. Epub 2019 Nov 12. J Am Heart Assoc. 2019. PMID: 31711390 Free PMC article.
-
Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.High Blood Press Cardiovasc Prev. 2020 Apr;27(2):157-164. doi: 10.1007/s40292-020-00370-5. Epub 2020 Mar 26. High Blood Press Cardiovasc Prev. 2020. PMID: 32219670 Free PMC article. Review.
Cited by
-
Development, Pilot, and Evaluation of a Qualitative Documentation Tool for Pharmacists to Share High Impact Patient Intervention Stories.Innov Pharm. 2024 Aug 21;15(3):10.24926/iip.v15i3.5772. doi: 10.24926/iip.v15i3.5772. eCollection 2024. Innov Pharm. 2024. PMID: 39483506 Free PMC article.
-
Rapid evidence review: Policy actions for the integration of public health and health care in the United States.Front Public Health. 2023 Mar 29;11:1098431. doi: 10.3389/fpubh.2023.1098431. eCollection 2023. Front Public Health. 2023. PMID: 37064661 Free PMC article. Review.
-
Pharmacy Contributions to Improved Population Health: Expanding the Public Health Roundtable.Prev Chronic Dis. 2020 Sep 24;17:E113. doi: 10.5888/pcd17.200350. Prev Chronic Dis. 2020. PMID: 32975507 Free PMC article. No abstract available.
-
State and Local Health Departments: Research, Surveillance, and Evidence-Based Public Health Practices.Prev Chronic Dis. 2023 Sep 28;20:E86. doi: 10.5888/pcd20.230142. Prev Chronic Dis. 2023. PMID: 37769248 Free PMC article. No abstract available.
-
Investigating the Prevalence and Types of Clinical Services Offered by Pharmacists in Federally Qualified Health Centers in South Carolina: A Qualitative, Cross-Sectional Survey.J Prim Care Community Health. 2024 Jan-Dec;15:21501319241295952. doi: 10.1177/21501319241295952. J Prim Care Community Health. 2024. PMID: 39508596 Free PMC article.
References
-
- Cosby AG, Bowser DM. The health of the Delta Region: a story of increasing disparities. J Health Hum Serv Adm 2008;31(1):58–71. - PubMed
-
- Mississippi State Department of Health. Heart disease and stroke prevention. http://msdh.ms.gov/msdhsite/_static/43,0,297.html. Accessed August 20, 2020.
-
- Mississippi State Department of Health. Mississippi Statistically Automated Health Resource System. http://mstahrs.msdh.ms.gov/. Accessed January 10, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous